This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Kapor J, Minshall ME, unis SL, Conner C, McCormick J, Seager C, Groleau D.Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting. Diabetes 57 (Suppl. 1): 98 abstr. 340-OR, Jun 2008
Rights and permissions
About this article
Cite this article
Insulin detemir an asset for diabetic patients in Canada. Pharmacoecon. Outcomes News 556, 6 (2008). https://doi.org/10.2165/00151234-200805560-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805560-00014